Pharmacy |
| ||
|
Accolate Generic Zafirlukast |
|
| ||
Home » Prescription Drugs 1 » Accolate Generic Zafirlukast Product Origin: EU (Turkey) This product is able to be sourced and supplied at excellent prices because of favourable cross border currency conversions. All products are authentic brand names and will include a product information insert in English. Medical Information: Accolate helps prevent asthma attacks. It is prescribed for long-term treatment. Accolate (zafirlukast) is an oral leukotriene receptor antagonist (LTRA) for the maintenance treatment of asthma. Available as a tablet it blocks the effects of substances which cause constriction of the airways build-up of mucus in the lungs and inflammation of the breathing passages. Accolate was the first LTRA to be marketed in the USA and is now approved in over 60 countries including the UK Japan Italy Spain Canada Brazil and China. Accolate is approved in the USA for adults and children aged 5 years and above. Accolate will not stop an asthma attack once it starts. You will still need to use an airway-opening medication when an attack occurs. Dosage:ADULTS The usual dose for adults and children 12 years of age and over is 20 milligrams twice a day. CHILDRENThe usual dose for children 7 to 11 years of age is 10 milligrams twice a day. Safety and effectiveness in children under 7 years of age have not been established. Buy Accolate Generic Zafirlukast and other Prescription Drugs 1 products online at Medstore. 3623
About Accolate Generic Zafirlukast: Product Type: Prescription Drugs 1 Accolate (Generic Zafirlukast ) Accolate (Generic Zafirlukast) Generic Zafirlukast 20mg 56 Tabs Generic Zafirlukast Accolate
View more Prescription Drugs 1 Pharmacy: Dozens of patents for name-brand drugs are due to expire within the next 14 months, and generic drugs will replace some of the most popular and widely advertised drugs used today. For millions of people worldwide, this means switching from familiar brands like Lipitor to generic equivalents. How will this affect drug companies, and what will be the impact on people who depend on expensive prescription medication? Here, a brief guide: Which drugs are scheduled to go generic? Some real blockbusters. "In the next two years, six of the 10 top-selling drugs will lose their patents," says Chris Woolston in the Los Angeles Times. Lipitor, the world's best-selling drug, which is used to lower cholesterol, will be available as a generic in November of this year. Another best-seller, the blood thinner Plavix, will lose its patent in May 2012. Other well-known drugs with expiring patents include the arthritis treatment Enbrel, the anti-psychotic Zyprexa, as well as drugs for bipolar disorder, HIV, high cholesterol, and other conditions.
| ||
